Cargando…

Off-label use of anti-IL-1 drugs in rheumatic diseases

Interleukin-1 (IL-1) plays a key role in the pathogenesis of different rheumatic diseases. There are now several agents available on the market capable of blocking IL-1. The proven effectiveness and excellent safety of these drugs makes them a possible therapeutic option in the treatment of IL-1 dri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefania, Silvia, Colia, Ripalta, Cinzia, Rotondo, Corrado, Addolorata, Cantatore, Francesco Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056561/ https://www.ncbi.nlm.nih.gov/pubmed/33855881 http://dx.doi.org/10.1177/20587384211006584

Ejemplares similares

Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine
por: Colia, Ripalta, et al.
Publicado: (2021)

Postmenopausal women presenting with spinal fractures and the importance of primary care: A case-series
por: Colia, Ripalta, et al.
Publicado: (2020)

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
por: Rotondo, Cinzia, et al.
Publicado: (2021)

Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis
por: Corrado, Addolorata, et al.
Publicado: (2021)

Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2015)

Correction: Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2015)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Osteoblast Role in Rheumatic Diseases
por: Corrado, Addolorata, et al.
Publicado: (2017)

Effects of Different Vitamin D Supplementation Schemes in Post-Menopausal Women: A Monocentric Open-Label Randomized Study
por: Corrado, Addolorata, et al.
Publicado: (2021)

Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.
por: Rotondo, Cinzia, et al.
Publicado: (2021)

Osteoblast Dysfunction in Non-Hereditary Sclerosing Bone Diseases
por: Giardullo, Liberato, et al.
Publicado: (2021)

Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study
por: Rotondo, Cinzia, et al.
Publicado: (2023)

1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2022)

The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties
por: Panaro, Maria Antonietta, et al.
Publicado: (2020)

Molecular Basis of Bone Aging
por: Corrado, Addolorata, et al.
Publicado: (2020)

Bone Involvement in Systemic Lupus Erythematosus
por: Rella, Valeria, et al.
Publicado: (2022)

Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis
por: Cici, Daniela, et al.
Publicado: (2019)

Pfeifer-Weber-Christian Disease: A Case Report and Review of Literature on Visceral Involvements and Treatment Choices
por: Rotondo, Cinzia, et al.
Publicado: (2020)

Bone Effects of Biologic Drugs in Rheumatoid Arthritis
por: Corrado, Addolorata, et al.
Publicado: (2013)

Macrophages and angiogenesis in rheumatic diseases
por: Maruotti, Nicola, et al.
Publicado: (2013)

JAK/STAT pathway and molecular mechanism in bone remodeling
por: Sanpaolo, Eliana Rita, et al.
Publicado: (2020)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease
por: Altomare, Alberto, et al.
Publicado: (2021)

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association
por: Favoino, Elvira, et al.
Publicado: (2018)

Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases
por: Giardullo, Liberato, et al.
Publicado: (2021)

Survey of off-label anti-IL1 treatments in France: preliminary data
por: Rossi-Semerano, L, et al.
Publicado: (2011)

Off-label use of rituximab in refractory pediatric rheumatic diseases: a single-center experience
por: Aguiar, Francisca, et al.
Publicado: (2014)

Osteoblast role in osteoarthritis pathogenesis
por: Maruotti, Nicola, et al.
Publicado: (2017)

PW03-019 – Survey of off-label ANTI-IL1 treatments in France
por: Rossi-Semerano, L, et al.
Publicado: (2013)

Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions
por: Neve, Anna, et al.
Publicado: (2014)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs
por: Kavadichanda, Chengappa, et al.
Publicado: (2021)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
por: Schinocca, Claudia, et al.
Publicado: (2021)

COVID-19 and Disease-Modifying Anti-rheumatic Drugs
por: D’Silva, Kristin M., et al.
Publicado: (2021)

The Role of IL-33 in Rheumatic Diseases
por: Duan, Lihua, et al.
Publicado: (2013)

Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
por: Moradi, Soroush, et al.
Publicado: (2020)

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs
por: Nakafero, Georgina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0549q06n00pjhdg8dlc3sbth3a